Juvenile systemic sclerosis

Key Points

• Juvenile systemic sclerosis is characterized by significant autoimmune activity and fibrosis, affecting young individuals.
• The study identifies molecular pathways involving collagen deposition as key drivers of disease progression.
• Assessment of various biomarkers related to fibrosis and immune response presents insights into disease mechanisms.
• This work emphasizes the need for targeted therapies to address the underlying autoimmunity, improving clinical outcomes.